The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
β‐Amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon ‐γ and ‘advanced glycation endproducts’ in a murine microglia cell line
Abstract
Summary: β‐Amyloid (Aβ) plaques are characteristic hallmarks of Alzheimer's disease (AD). In AD, it has been suggested that activation of microglial cells might be the link between Aβ deposition and neuronal degeneration. Activated microglia are associated with senile plaques and produce free radicals and inflammatory cytokines. However, it is still not clear whether Aβ needs a prestimulated environment to exert its proinflammatory potential. Advanced glycation endproducts (AGEs), protein‐bound oxidation products of sugars, have been shown to accumulate in senile plaques and could induce a silent but chronic inflammation in the AD brain. We tested whether Aβ acts as an amplifier of a submaximal proinflammatory response initiated by exposure to chicken egg albumin‐AGE, lipopolysaccharide or interferon‐γ. Synthetic Aβ was used to produce three different samples (Aβ‐fibrilar; Aβ‐aggregated; Aβ‐AGE), which were characterized for β‐sheeted fibrils by the thioflavin‐T test and electron microscopy. As markers of microglial activation, nitric oxide, interleukin‐6, macrophage‐colony stimulation factor and tumour necrosis factor‐α production was measured. All three Aβ samples alone could not induce a detectable microglial response. The combination of Aβ preparations, however, with the coinducers provoked a strong microglial response, whereby Aβ‐AGE and fibrilar Aβ were more potent inflammatory signals than aggregated Aβ. Thus, Aβ in senile plaques can amplify microglial activation by a coexisting submaximal inflammatory stimulus. Hence, anti‐inflammatory therapeutics could either target the primary proinflammatory signal (e.g. by limiting AGE‐formation by AGE inhibitors or cross‐link breakers) or the amplifyer Aβ (e.g. by limiting Aβ production by β‐ or γ‐secretase inhibitors).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Changes in inflammatory markers in Alzheimer's disease are often associated with the accumulation of Aβ following amyloidogenic processing of APP.
“Changes in inflammatory markers in AD are often associated with the accumulation of Aβ following amyloidogenic processing of APP [43, 44].”
Citations
Cites
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287 · cited 2×
“The centres of this inflammatory response in AD are the senile plaques, extracellular deposits composed mainly of insoluble aggregates of Ab protein surrounded by reactive glial cells (Selkoe, 1991; McGeer & McGeer, 1995; Xia & Hyman, 1999).”
BackgroundNonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
in 't Veld, B. A., Ruitenberg, A., Hofman, A., Launer, L. J., van Duijn, C. M., Stijnen, T., Breteler, M. M. B., & Stricker, B. H. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010178 · Cited by 1,196
Weldon, D. T., Rogers, S. D., Ghilardi, J. R., Finke, M. P., Cleary, J. P., O’Hare, E., Esler, W. P., Maggio, J. E., & Mantyh, P. W. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-06-02161.1998 · Cited by 348
Itagaki, S., McGeer, P. L., & Akiyama, H. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90690-8 · Cited by 271
Yates, S. L., Burgess, L. H., Kocsis‐Angle, J., Antal, J. M., Dority, M. D., Embury, P. B., Piotrkowski, A. M., & Brunden, K. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741017.x · Cited by 202
The amyloid beta-protein of Alzheimer's disease is chemotactic for mononuclear phagocytes
Davis, J. B., McMurray, H. F., & Schubert, D. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)92317-q · Cited by 93
Galimberti, D., Baron, P., Meda, L., Prat, E., Scarpini, E., Delgado, R., Catania, A., Lipton, J. M., & Scarlato, G. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1276 · Cited by 83
Flagged first, then by citations
Research works printed but not linked: 44
- 10.1074/jbc.275.11.7918 · DOI · Paper page
- 10.1016/0006-8993(92)90380-R · DOI
- 10.1073/pnas.040558497 · DOI
- 10.1002/glia.440070309 · DOI
- Bucala R., 1992, Posttranslational Modifications of Proteins, 53
- 10.1016/S0006-8993(01)03362-5 · DOI
- 10.1038/415462a · DOI
- 10.1007/BF02815200 · DOI
- 10.1016/0197-4580(96)00116-9 · DOI
- 10.1002/(SICI)1098-1136(199911)28:2<114::AID-GLIA3>3.0.CO;2-O · DOI
- 10.1016/0165-6147(94)90057-4 · DOI
- 10.1016/0006-8993(95)00646-8 · DOI
- 10.1016/0003-2697(82)90118-X · DOI
- 10.1038/366562a0 · DOI
- 10.1046/j.1432-1327.1998.2510208.x · DOI
- 10.1006/bbrc.1994.1326 · DOI
- 10.1093/brain/awf235 · DOI
- 10.1002/pro.5560020312 · DOI
- 10.1016/0197-4580(95)80009-G · DOI
- 10.1073/pnas.91.25.12243 · DOI · Paper page
- 10.1002/glia.1072 · DOI
- 10.1006/exnr.2001.7732 · DOI · Paper page
- 10.1002/glia.440070114 · DOI · Paper page
- 10.1111/j.1749-6632.2000.tb06922.x · DOI
- 10.1016/S0925-4439(96)00062-2 · DOI
- 10.1007/BF02260940 · DOI
- 10.1074/jbc.273.33.20967 · DOI
- 10.1016/S0168-0102(99)00071-1 · DOI
- 10.1016/S0014-5793(99)00731-0 · DOI
- 10.1523/JNEUROSCI.22-03-00854.2002 · DOI
- 10.1016/S0002-9440(10)65659-3 · DOI
- 10.1055/s-2000-13204 · DOI
- 10.1002/j.1460-2075.1991.tb07761.x · DOI
- 10.1016/0896-6273(91)90052-2 · DOI · Paper page
- 10.1097/00005072-199409000-00003 · DOI
- 10.1046/j.1471-4159.2001.00240.x · DOI
- 10.1073/pnas.91.11.4766 · DOI · Paper page
- 10.1006/exnr.1996.6373 · DOI · Paper page
- 10.1016/S0167-4889(00)00078-1 · DOI
- 10.1046/j.0953-816x.2001.01820.x · DOI
- 10.1016/S0006-8993(01)02872-4 · DOI
- 10.3109/13550289909029743 · DOI
- Yan S.D., 1998, RAGE–A beta interactions in the pathophysiology of Alzheimer's disease, Rest. Neurol. Neurosci., 12, 167
- 10.1073/pnas.94.10.5296 · DOI
Cited by
Sorted by citations
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease
Srikanth, V., Maczurek, A., Phan, T., Steele, M., Westcott, B., Juskiw, D., & Münch, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.016 · Cited by 524
Self-citationBiomarkers for Alzheimer’s Disease
Guzman-Martinez, L., Maccioni, R. B., Farías, G. A., Fuentes, P., & Navarrete, L. P. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190517121140 · Cited by 87
Metformin activation of AMPK suppresses AGE-induced inflammatory response in hNSCs
Chung, M.-M., Nicol, C. J., Cheng, Y.-C., Lin, K.-H., Chen, Y.-L., Pei, D., Lin, C.-H., Shih, Y.-N., Yen, C.-H., Chen, S.-J., et al. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.01.017 · Cited by 66
Pilat, D., Paumier, J.-M., García-González, L., Louis, L., Stephan, D., Manrique, C., Khrestchatisky, M., Di Pasquale, E., Baranger, K., & Rivera, S. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02407-z · Cited by 28
Metadata
- Authors
- Gasic‐Milenkovic, J., Dukic‐Stefanovic, S., Deuther‐Conrad, W., Gärtner, U., & Münch, G.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2003-02
- Volume
- 17
- Issue
- 4
- Pages
- 813-821
- ISSN
- 0953-816X
- 1460-9568
- Cited by
- 87
- References
- 8
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review